Figure 3.
Relative cytotoxicity neutralization activity of FKB327, US‐licensed adalimumab reference product, and EU‐approved adalimumab reference product. RP, reference product (Humira®)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.